| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |